IL9 and cancer: Our study brings an important contribution to the field by demonstrating that dysbiosis affects important players in tumour immunity, such as IL-9-producing T cells, and suggests that these cells should be carefully considered in further studies regarding the impacts of the host microbiota on cancer immunology and therapy.